Because data from studies in patients with progressive fibrotic ILD suggest that anti-fibrotic therapy could have a role in preventing AE-ILD [27], this therapy may also improve prognosis in MPO-ANCA-positive ILD, particularly in non-MPA-ILD. Here, MPO is linked to microscopic polyangiitis.